Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
FEBS J. 2013 Jul;280(14):3194-204. doi: 10.1111/febs.12272. Epub 2013 May 3.
Telomeres are nucleoprotein structures found at the ends of linear chromosomes. Telomeric DNA shortens with each cell division, effectively restricting the proliferative capacity of human cells. Telomerase, a specialized reverse transcriptase, is responsible for de novo synthesis of telomeric DNA, and is the major physiological means by which mammalian cells extend telomere length. Telomerase activity in human soma is developmentally regulated according to cell type. Failure to tightly regulate telomerase has dire consequences: dysregulated telomerase activity is observed in more than 90% of human cancers, while haplo-insufficient expression of telomerase components underlies several inherited premature aging syndromes. Over the past decade, we have significantly improved our understanding of the structure-activity relationships between the two core telomerase components: telomerase reverse transcriptase and telomerase RNA. Genetic screening for telomerase deficiency syndromes has identified new partners in the biogenesis of telomerase and its catalytic functions. These data revealed a level of regulation complexity that is unexpected when compared with the other cellular polymerases. In this review, we summarize current knowledge on the structure-activity relationships of telomerase reverse transcriptase and telomerase RNA, and discuss how the biogenesis of telomerase provides additional regulation of its actions.
端粒是线性染色体末端的核蛋白结构。端粒 DNA 在每次细胞分裂时都会缩短,从而有效地限制了人类细胞的增殖能力。端粒酶是一种特殊的逆转录酶,负责端粒 DNA 的从头合成,是哺乳动物细胞延长端粒长度的主要生理手段。根据细胞类型,人体细胞中端粒酶的活性受到发育调控。不能严格调控端粒酶会产生严重的后果:超过 90%的人类癌症中观察到端粒酶活性失调,而端粒酶成分的单倍体不足表达则是几种遗传性早衰综合征的基础。在过去的十年中,我们对两种核心端粒酶成分(端粒酶逆转录酶和端粒酶 RNA)之间的结构-活性关系有了显著的认识。对端粒酶缺陷综合征的遗传筛选确定了端粒酶生物发生及其催化功能的新伙伴。与其他细胞聚合酶相比,这些数据揭示了一种调节复杂性,这是出乎意料的。在这篇综述中,我们总结了端粒酶逆转录酶和端粒酶 RNA 的结构-活性关系的最新知识,并讨论了端粒酶的生物发生如何为其作用提供额外的调节。